The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention

Humans are considered "superorganisms," harboring a diverse microbial collective that outnumbers human cells 10 to 1. Complex and gravely understudied host- and microbe-microbe interactions-the product of millions of years of host-microbe coevolution-govern the superorganism in almost every aspect of life functions and overall well-being. Abruptly disrupting these interactions via extrinsic factors has undesirable consequences for the host. On the other hand, supplementing commensal or beneficial microbes may mitigate perturbed interactions or enhance the interactive relationships that ultimately benefit all parties. Hence, immense efforts have focused on dissecting the innumerable host- and microbe-microbe relationships to characterize if a "positive" or "negative" interaction is at play and to exploit such behavior for broader implications. For example, microbiome research has worked to identify and isolate naturally antipathogenic microbes that may offer therapeutic potential either in a direct, one-on-one application or by leveraging its unique metabolic properties. However, the discovery and isolation of such desired therapeutic microbes from complex microbiota have proven challenging. Currently, there is no conventional technique to universally and functionally screen for these microbes. With this said, we first describe in this review the historical (probiotics) and current (fecal microbiota or defined consortia) perspectives on therapeutic microbes, present the discoveries of therapeutic microbes through exploiting microbe-microbe and host-microbe interactions, and detail our team's efforts in discovering therapeutic microbes via our novel microbiome screening platform. We conclude this minireview by briefly discussing challenges and possible solutions with therapeutic microbes' applications and paths ahead for discovery.

Quantitative analysis of binding affinities and characterization of β-lactoglobulin and λ-carrageenan as a function of pH

λ-Carrageenan (λcar) interacted with β-lactoglobulin (βlg) immediately to form βlg-λcar complexes when used as an additive in milk. The formation of complexes is the key process through which to explore the bioapplication of λcar, which is a complicated process and influenced by many factors. In this study, the formation process and effect of pH were ascertained by the binding affinity, hydrodynamic diameter, and secondary structure. Results showed that the interaction was spontaneously exothermic and the complexes were soluble. The binding affinities (Ka) decreased from 9.0 ± 1.3 × 10⁵ to 1.3 ± 0.8 × 10⁵  M^-1 , and the stoichiometry also decreased as the pH was increased from 4 to 7. Furthermore, DLS showed a larger hydrodynamic diameter of the complexes at lower pH. Moreover, the complexes induced a change in the secondary structural components of βlg at lower pH. PRACTICAL APPLICATIONS: The secondary structure of βlg was changed by the interaction of λcar, which resulted in βlg-λcar complexes under acidic conditions. The soluble βlg-λcar complexes showed a good stability against aggregation. Thus, they can enhance the textural properties and stability of acidic dairy drinks, and can be used to accurately formulate ingredients in the food ingredient industry.